Oric Pharmaceuticals, Inc. Common Stock

ORICNASDAQUSD
10.59 USD
0.04 (0.36%)🟢LIVE (AS OF 10:11 AM EDT)
🟢Market: OPEN
Open?$10.71
High?$10.95
Low?$10.54
Prev. Close?$10.63
Volume?126.2K
Avg. Volume?2.3M
VWAP?$10.72
Rel. Volume?0.06x
Bid / Ask
Bid?$10.68 × 100
Ask?$12.32 × 100
Spread?$1.64
Midpoint?$11.50
Valuation & Ratios
Market Cap?1.2B
Shares Out?100.4M
Float?55.4M
Float %?56.9%
P/E Ratio?N/A
P/B Ratio?3.10
EPS?-$1.16
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?14.13Strong
Quick Ratio?14.13Strong
Cash Ratio?2.24Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A
P/B?
3.10FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-8.1CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-33.7%WEAK
ROA?
-31.7%WEAK
Cash Flow & Enterprise
FCF?$-111682000
Enterprise Value?$1.1B
News
Profile
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Employees
104
Market Cap
1.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-04-24
Address
240 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 388-5600